Flagship explainer

How YUBO INTERNATIONAL BIOTECH LIMITED makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$12353 · 100%Cost of revenue$4188 · 34%Gross profit$8165 · 66%Operating income−$1.2M · −9615%Income before tax−$1.2M · −9617%Income tax$0 · 0%Net income−$1.1M · −8737%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$12353100%
Cost of revenue$418834%
$816566%
−$1.2M−9615%
Income before tax−$1.2M−9617%
Income tax$00%
−$1.1M−8737%
Source: · event Dec 31, 2025 · retrieved Sep 4, 2026 · annual-row source set
Embed this chart

View the full YUBO INTERNATIONAL BIOTECH LIMITED analysis at Buy Like Buffett